The AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with “frequently changing and confusing” COVID-19 data collection efforts.

“CMS’ decision to threaten hospital Medicare participation is a direct rebuke of the clear willingness displayed by America’s hospitals and health systems to provide all relevant data to the federal government,” AHA said today in comments on the agency’s Aug. 25 interim final rule. “It threatens not only to negatively impact the collaborative work in which our members have engaged, but also needlessly jeopardizes the financial viability of hospitals across the country on which millions of Americans rely. The previous success of COVID-19 data reporting was built on partnerships not mandates; the agency should continue along this path and reject pursing this unnecessary approach to COVID-19 data reporting. In moving forward with this interim final rule, the agency is abandoning collaboration and teamwork for a heavy-handed regulatory approach.”

In addition, the AHA said it opposes CMS’ policy of making the reporting of COVID-19 testing data a CoP for laboratories and urged the agency “to rescind this CoP, or at a minimum, to rescind the rule’s provisions imposing civil monetary penalties on labs for non-compliance.”

The AHA also commented on provisions in interim final rule related to changes to quality measurement requirements; nursing home provisions and limits on COVID-19 testing.

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 26 that average premiums for Medicare Advantage and Part D would decline slightly in 2026.…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a…